RecruitingPhase 3NCT04965038
Early Reperfusion Therapy With Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion
Studying Central retinal artery occlusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Tuebingen
- Intervention
- Tenecteplase (until trial protocol V04: Alteplase)(drug)
- Enrollment
- 422 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2026
Study locations (1)
- University Hospital Tuebingen, Tübingen, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04965038 on ClinicalTrials.govOther trials for Central retinal artery occlusion
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07482228Long-term Clinical Outcomes After Retinal Artery OcclusionChonnam National University Hospital
- RECRUITINGNANCT07151755Microneedle Intra-Arterial Injection for Retinal Artery OcclusionSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT06500728Visual Involvement in Giant Cell ArteritisASST Fatebenefratelli Sacco
- RECRUITINGNANCT07545473Retinal Hyperspectral Imaging in Neurodegenerative DiseasesCenter for Eye Research Australia